A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients

NCT00001085 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

94

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Amprenavir
DRUG: Lamivudine
DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)